DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» New chemical entity
New chemical entity
Medical Prescription Market Definitions
IND Exemptions Chart
United States District Court for the District of Columbia
New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products
Natural Products As Leads to Potential Drugs: an Old Process Or the New Hope for Drug Discovery?
1097.Full.Pdf
Generic Drug Development and Safety Evaluation
Pharmacophore Hybridisation and Nanoscale Assembly to Discover Self-Delivering Lysosomotropic New-Chemical Entities for Cancer Therapy
Seps Science Article
205060Orig1s000
Quantitative Structure-Activity Relationship Modeling to Predict Drug-Drug Interactions Between Acetaminophen and Ingredients in Energy Drinks
Analogue-Based Drug Discovery: Contributions to Medicinal Chemistry Principles and Drug Design Strategies
Exclusivity Strategies in the United States and European Union by Carolyne Hathaway, John Manthei and Cassie Scherer
Admetlab: a Platform for Systematic ADMET Evaluation Based on a Comprehensively Collected ADMET Database
New Spiro[Cycloalkane-Pyridazinone] Derivatives with Favorable Fsp3 Character
Guideline on the Pharmacokinetic and Clinical Evaluation of Modified Release Dosage Forms
Module 2: Vaccines and Drugs: Similarities and Differences
Application of Static Models to Predict Midazolam Clinical Interactions in the Presence of Single Or Multiple Hepatitis C Virus Drugs S
Top View
Integrated Approach to Nature As Source of New Drug Lead
Identification and Development of New Chemical Entities to Treat Visceral Leishmaniasis: a Bumpy Road
Recent Trends in Enzyme Inhibition and Activation in Drug Design
Glossary of Terms Used in Medicinal Chemistry. Part II (IUPAC Recommendations 2013)*
Kentucky Department for Medicaid Services Drug Review and Options
Open Access in Silico Tools to Predict the ADMET Profiling of Drug Candidates
Barriers to Clinical Translation with Diagnostic Drugs
GLOSSARY of TERMS USED in MEDICINAL CHEMISTRY (IUPAC Recommendations 1998)
Defining Active Ingredient: the U.S
The Significance of Technology in Drug Discovery and Development
FERRING PHARMS. INC., ) ) Plaintiffs, ) ) V
Pharmacokinetic Study with Computational Tools in the Medicinal Chemistry Course
Exclusivity–Which One Is for Me?
The Medicinal and Biological Chemistry (MBC) Library: an Efficient
Andas: Impurities in Drug Substances
New Laws Narrow the Scope of Market Exclusivity and Seek to Increase Awareness of Biosimilars
Drug Metabolism in Preclinical Development
Principles of Safety Pharmacology
GLOSSARY of TERMS USED in MEDICINAL CHEMISTRY (IUPAC Recommendations 1998)
The Use of Preclinical Pharmacokinetic and Pharmacodynamic Data to Predict Clinical Doses: Current and Future Perspectives Paul Morgan*
Emend Exclusivity Determination 22-023S000 ADMINISTRATION And
A Look at the Drug Discovery, Development and Approval Processes
NDA Classification Codes
Chemical Compounds and Biologics Developing Issues Relevant To
Chemography of Natural Product Space
Regulatory Exclusivity Reform in the 115Th Congress
The Origin of FDA Approved Natural Product New Chemical Entities
Biden Administration Inks Bills to Increase Drug Competition
1 New Trends in Drug Discovery
New Chemical Entity Exclusivity Determinations for Certain Fixed-Combination Drug Products
E-Z-HD-Barium-Sulfate-Exclusivity
Preclinical Drug Development
New Chemical Entity Exclusivity Determinations for Certain Fixed-Combination Drug Products
Rethinking FDA Regulation of Complex Products
Fda Guidance New Chemical Entity
Quantitative Structure-Antioxidant Activity Models of Isoflavonoids: a Theoretical Study
Guidance for Industry
The Effect of Data Curation on the Accuracy of Quantitative Structure-Activity Relationship Models